Substance / Medication

Ibopamine

Overview

Active Ingredient
ibopamine
RxNorm CUI
51253

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma.
Ugahary Luana Cahya, Ganteris Elisabeth, Veckeneer Marc et al. · Am J Ophthalmol · 2006
PMID: 16490513RCT
Ibopamine challenge testing becomes negative following successful trabeculectomy surgery.
Landers John, Ullrich Katja, Craig Jamie E · Clin Exp Ophthalmol · 2016
PMID: 26575026Trial
Ibopamine challenge testing differentiates glaucoma suspect, stable glaucoma and progressive glaucoma cases.
Landers John, Ullrich Katja, Craig Jamie E · Clin Exp Ophthalmol · 2015
PMID: 26140527Trial
Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment.
Marchini Giorgio, Babighian Silvia, Tosi Roberto et al. · Invest Ophthalmol Vis Sci · 2003
PMID: 12506086Trial
Effects of ibopamine eye drops on intraocular pressure and aqueous humor flow in healthy volunteers and patients with open-angle glaucoma.
Azevedo H, Ciarniello M G, Rosignoli M T et al. · Eur J Ophthalmol · 2003
PMID: 12872794Trial
Effect of ibopamine on aqueous humor production in normotensive humans.
McLaren Jay W, Herman David C, Brubaker Richard F et al. · Invest Ophthalmol Vis Sci · 2003
PMID: 14578408Trial
Effects of 2% ibopamine on pupil, refraction, anterior segment anatomy and intraocular pressure.
Marchini G, Babighian S, Tosi R et al. · J Ocul Pharmacol Ther · 2001
PMID: 11436942Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ibopamine (substance)
SNOMED CT
717169003
UMLS CUI
C0123043
RxNorm CUI
51253

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.